Showing results (581-590 of 2,903) with videos related to
Sort By:
Pageof 291
Cancer Gene Therapy|July 2, 2019
Targeting mTOR suppressed colon cancer growth through 4EBP1/eIF4E/PUMA pathwayHuanan Wang, Yeying Liu, Jie Ding, et al.Cancer Gene Therapy|April 7, 2023
Use of CRISPR-based screens to identify mechanisms of chemotherapy resistanceGeorge Alyateem, Heidi M Wade, Aaron A Bickert, et al.Cancer Gene Therapy|April 17, 2023
Lycium barbarum glycopeptide targets PER2 to inhibit lipogenesis in glioblastoma by downregulating SREBP1cJian Yao, Jian-Wen Hui, Yan-Jun Chen, et al.Cancer Gene Therapy|April 16, 2021
Vector engineering, strategies and targets in cancer gene therapyVijayata Singh, Nusrat Khan, Giridhara R JayandharanCancer Gene Therapy|August 7, 2012
Enhanced radiosensitivity of non-small-cell lung cancer (NSCLC) by adenovirus-mediated ING4 gene therapyC Ling, Y Xie, D Zhao, et al.Cancer Gene Therapy|July 14, 2012
Effects of interferon-α-transduced tumor cell vaccines and blockade of programmed cell death-1 on the growth of established tumorsR Omori, J Eguchi, K Hiroishi, et al.Cancer Gene Therapy|August 8, 2020
Autophagy inhibition is the next step in the treatment of glioblastoma patients following the Stupp eraXiaoran Zhang, Christopher P Deibert, Wi-Jin Kim, et al.Cancer Gene Therapy|August 8, 2020
Expression pattern of m6A regulators is significantly correlated with malignancy and antitumor immune response of breast cancerXiaofang He, Liqiang Tan, Jing Ni, et al.Cancer Gene Therapy|August 7, 1998
A recombinant adenoviral vector expressing full-length human retinoblastoma susceptibility gene inhibits human tumor cell growthG W Demers, M P Harris, S F Wen, et al.Cancer Gene Therapy|August 7, 1998
Protection of CCRF-CEM human lymphoid cells from antifolates by retroviral gene transfer of variants of murine dihydrofolate reductaseS M Mareya, B P Sorrentino, R L BlakleyPageof 291